Adapt Pharma Operations Ltd.

2 cases as plaintiff.

Cases

Active

2 closed

Filed

—

Top venue

Fed. Cir.

2 cases

Watchlist

Get alerted when Adapt Pharma Operations Ltd. sues again.

Email-only, free, anonymous. We'll notify you when Adapt Pharma Operations Ltd. files another patent-infringement lawsuit. One-click unsubscribe from any alert.

Adapt Pharma Operations Ltd. v. Teva Pharmaceuticals USA, Inc.

affirmed

Docket:: 2020-2106
Court:: U.S. Court of Appeals for the Federal Circuit
Terminated:: 2022-02-10

Patents:9629965

π Adapt Pharma Operations Ltd.Δ Teva Pharmaceuticals USA, Inc.

Federal Circuit appeal from the D.N.J. invalidity judgment. On February 10, 2022, the court affirmed, finding no error in the obviousness conclusion as to the asserted claims including U.S. 9,629,965 claims 21, 24, and 25; Newman, J., dissented.

Adapt Pharma Operations Ltd. v. Teva Pharmaceuticals USA, Inc.

affirmed

Docket:: 20-2106
Court:: U.S. Court of Appeals for the Federal Circuit
Terminated:: 2022-02-10

Patents:9211253 9468747

π Adapt Pharma Operations Ltd.Δ Teva Pharmaceuticals USA, Inc.

Federal Circuit appeal from the D.N.J. Hatch-Waxman decision. The court affirmed the invalidity/obviousness holding on February 10, 2022 (Opinion by Stoll, joined by Prost; Newman dissenting). The narrative notes the appellate opinion discusses the '747 patent and does not confirm the '253 patent's role.